LH · Full Picture

LABCORP HOLDINGS INC. — the full picture

Earnings window · 2026-07-15 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Revenue Performance and Mix · Revenue growth & mixPriority 78
    +32.1% revenue (realized); 2 sources (news, sec_filing); structured_verified
    For the three months ended June 30, 2026, the Company’s revenues were $3,731.1, an increase of 5.8% from $3,527.3 for the corresponding period in 2025.
  2. Capital Return Program · Buybacks & dividendsPriority 77
    -6.6% cash; 3 forward row(s); structured_verified
    On July 8, 2026, the Board authorized the repurchase of an additional $1,000.0 in the maximum value of the Company’s shares, bringing the total share repurchase authorization to $1,378.6 maximum value of shares of Common Stock.
  3. Operating Income and Margins · Operating income & profitabilityPriority 71
    +13.2% operating_income (realized); structured_verified
    Segment operating income for the six months ended June 30, 2026, was $1,244.2 compared to $1,140.5 in the corresponding period in 2025, an increase of 9.1%.
  4. Gross Margin Drivers · Gross marginPriority 69
    -10.8% operating_income (realized); structured_verified
    Cost of revenues for the three months ended June 30, 2026, were $2,619.1, an increase of 5.6% from $2,481.1 in the corresponding period in 2025.
  5. Liquidity and Debt Position · Debt, leverage & refinancingPriority 68
    -5.0% liability; 1 forward row(s); structured_verified
    Net cash used for investing activities for the six months ended June 30, 2026, was $(688.3) compared to $(430.1) for the six months ended June 30, 2025.
  6. Interest Rate and Refinancing Exposure · Interest ratesPriority 60
    quote_verified
    On June 1, 2026, the net proceeds of the 2026 Term Loan were used to redeem the Company’s outstanding 1.55% senior notes due 2026.
  7. End-Market Demand Trends · Demand, orders & backlogPriority 48
    quote_verified
    Dx total volume, measured by requisitions, increased by 3.0% for the three months ended June 30, 2026, as organic volume increased by 1.8% and acquisition volume, net of divestitures, contributed 1.3%.
  8. Acquisition / Partnership / Divestiture · M&A and divestituresPriority 45
    +0.4% assets; 2 forward row(s); structured_verified
    On June 28, 2026, the Company entered into an agreement to acquire select assets of an outreach laboratory services business for a purchase price of approximately $155.0, and the transaction is anticipated to close in the third quarter of 2026, subject to customary closing conditions and applicable regulatory approvals.
  9. Guidance / Outlook · Guidance & outlookPriority 45
    quote_verified
    Labcorp raised its full-year guidance for revenue and adjusted EPS.
  10. Manufacturing and Capacity · Supply chain & operationsPriority 45
    -0.5% liability; 1 forward row(s); structured_verified
    The Company has a noncancelable contract to purchase supplies inventory with expected total future minimum payments of $115.4, including $20.9 for the remainder of 2026, $20.5 in 2027, and $74.0 in 2028.
  11. Net Income and Profitability · Operating income & profitabilityPriority 45
    quote_verified
    Q2 2026 net income was US$298.7 million.
  12. Operating Expense Trends · Operating expenses (SG&A)Priority 44
    +1.8% margin (realized); quote_verified
    SG&A as a percentage of revenues were 15.5% for the three months ended June 30, 2026, compared to 16.4% for the three months ended June 30, 2025.

Threads by pillar

Revenue & Demand Priority 83 · 3 threads

Costs & Margins Priority 87 · 6 threads

Capital & Balance Sheet Priority 87 · 4 threads

Strategy & Portfolio Priority 45 · 1 thread

Legal, Regulatory & Policy Priority 29 · 1 thread

Guidance & Outlook Priority 45 · 1 thread

Macro & Market Conditions Priority 60 · 1 thread

Unclassified Priority 43 · 2 threads

Expected impact by metric

metricforward netforward grossrealized
cash-7.0%+7.0%+6.4%
liability-5.6%+5.6%-4.0%
assets+0.4%+0.4%—
operating_income——+3.7%
margin——+5.2%
net_income——-0.4%
revenue——+32.0%